首页> 外文OA文献 >Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

【2h】

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

机译：基线纤维蛋白溶解状态和未来静脉血栓形成的风险。内源组织型纤溶酶原激活剂和纤溶酶原激活剂抑制剂的前瞻性研究。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P M Ridker; D E Vaughan; M J Stampfer; J E Manson; C Shen; L M Newcomer; S Z Goldhaber; C H Hennekens;
展开▼
作者单位

展开▼
年度 1992
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Endogenous fibrinolytic potential in tissue-plasminogen activator-modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosis. [J] . Spodsberg E. H., Wiinberg B., Jessen L. R., Veterinary Clinical Pathology . 2013,第3期

机译：在患有易患血栓形成的疾病的狗中，组织纤溶酶原激活物修饰的血栓弹性成像分析中的内源性纤溶潜力显着降低。
2. Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis [J] . Vuckovic Biljana A., Djeric Mirjana J., Tomic Branko V., Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2018,第1期

机译：纤维蛋白溶解活性和纤溶酶原激活剂抑制剂-14g / 5g多态性对静脉血栓形成风险的影响
3. Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis [J] . Vuckovic Biljana A., Djeric Mirjana J., Tomic Branko V., Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2018,第1期

机译：纤维蛋白溶解活性和纤溶酶原激活剂抑制剂-14g / 5g多态性对静脉血栓形成风险的影响
4. The Changes of Tissue-Type Plasminogen Activator and Matrix Metalloproteinases in Neonatal Mice with Hypoxic-Ischemic Encephalopathy [C] . Xu JianWen, Wang Wei, Zhao XiaoZhen, International Conference on Mechanical Engineering and Intelligent Systems . 2012

机译：缺氧缺血性脑病新生小鼠组织型纤溶酶原激活剂和基质金属蛋白酶的变化
5. A structure-function analysis of the lysine-binding kringle 2 domains of human tissue-type plasminogen activator and human plasminogen by strategic mutagenesis. [D] . Nilsen, Stephanie Lynn. 1999

机译：通过战略诱变对人体组织型纤溶酶原激活物和纤溶酶原的赖氨酸结合kringle 2域的结构功能分析。
6. The interaction of streptokinase.plasminogen activator complex tissue-type plasminogen activator urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro. [O] . R Cassels, R Fears, R A Smith 1987

机译：链激酶纤溶酶原激活物复合物组织型纤溶酶原激活物尿激酶及其酰化衍生物与纤维蛋白原和纤维蛋白原的溴化氰消化物的相互作用。与体外纤维蛋白溶解能力的关系。
7. MP651A PROSPECTIVE RANDOMIZED CROSS-OVER STUDY COMPARING TWO LOCK SOLUTIONS USED ON TUNNELLED CENTRAL VENOUS CATHETERS OF HEMODIALYSIS: CITRATE PLUS ONCE A WEEK ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS CITRATE ALONE [O] . Rita Magrico, José Santos, Susana Colaço, 2017

机译：MP651A预期随机交叉研究比较血液透析中央静脉导管的两次锁定解决方案：柠檬酸盐加上每周一次施用重组组织纤溶酶原激活剂与单独的柠檬酸盐

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

著录项

引文网络

相似文献

相关主题

期刊订阅